Empa-M12.5+500mg Tablets 14`s is a prescription medication used to treat adults with type 2 diabetes to improve blood sugar control. It contains two active ingredients: empagliflozin and metformin. Empagliflozin belongs to a class of drugs known as sodium-glucose cotransporter-2 (SGLT2) inhibitors, which work by increasing the amount of sugar that is removed from the body through the urine. Metformin is a type of medication known as a biguanide, which helps to lower blood sugar by decreasing the amount of sugar produced by the liver and increasing the sensitivity of muscle cells to insulin.
Empa-M12.5+500mg tablets are taken by mouth, usually once a day. The recommended dose is one tablet once daily, but the dose may be adjusted based on the individual’s blood sugar levels and response to treatment. It is important to take the medication exactly as prescribed by a healthcare provider. The tablets should be taken at the same time each day to maintain a consistent level in the body.
Empa-M12.5+500mg tablets may cause side effects, including urinary tract infections, genital infections, and increased urination. It may also increase the risk of dehydration and low blood pressure. It is important to notify a healthcare provider if these or any other side effects occur. Empa-M12.5+500mg tablets may also interact with other medications, so it is important to tell a healthcare provider about all the medications being taken.
Empa-M12.5+500mg tablets are a prescription medication and should be taken only under the direction of a healthcare provider. It is important to follow the prescribed dosing and not to stop taking the medication without first consulting with a healthcare provider.